Biotech Stocks Newsletter – April 6, 2018


Is Opportunity Knocking In The Biotech Sector

Big pharma is making a push right now to expand margins and investing billions into innovation for new treatments and drug therapies. In fact, drug companies have created venture capital funds and incubators to invest in promising start-ups working on new drug technologies.

Recently One Biotech Company has brought on new team members that have all had direct experience with many of the “industry leading” companies within the biotech industry.over the last 6 trading sessions, investors have already seen the volatile marktet for this stock spike up aa run of over 40%. After a recent day of consolidation, Wednesday’s late afternoon trading could be a cue for another run in the making!


PTC Therapeutics, Inc. and CHDI Foundation, Inc. to Jointly Work on a Program to Reduce Huntingtin Protein

PTC Therapeutics, Inc. has entered into an accord with CHDI Foundation, Inc. to jointly work on advancing Huntington’s disease program of PTC. The slicing technology platform of PTCT will be used to optimize the small molecule compounds to reduce huntingtin protein production.

SEE FOR YOURSELF CLICK HERE! is owned by MIDAM VENTURES LLC., a Florida Corporation that has been compensated $1,800,000.00 by a GT Biopharma Inc. for a period beginning August 1, 2017 and ending April. 30, 2018 to publicly disseminate information about (GTBP). We own zero shares. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER


Please enter your name here
Please enter your comment!